Real-time enrollment status for this binge eating disorder clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 2:28 AM UTC
| NCT Number | NCT06413433 |
| Recruiting Status | Recruiting |
| Condition | Binge Eating Disorder |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Axsome Therapeutics, Inc. |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of September 3, 2026: Clinical trial NCT06413433 is currently recruiting participants. This phase3 study for binge eating disorder is actively seeking new participants at 45 locations across the United States. The study is sponsored by Axsome Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06413433 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06413433 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.